Status:
COMPLETED
Treatment of Androgenetic Alopecia in Males
Lead Sponsor:
Lexington International, LLC
Conditions:
Androgenetic Alopecia
Hair Loss
Eligibility:
MALE
25-60 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 7 Beam model in promoting hair growth in males diagnosed with androgenetic alopecia when treatment is applied as dir...
Detailed Description
This is randomized, double-blind, control device clinical study across 2 sites, evaluating changes in terminal hair-count in the evaluation zone having evidence of androgenetic alopecia (miniaturized ...
Eligibility Criteria
Inclusion
- Diagnosis of androgenetic alopecia
- Fitzpatrick Skin Types I-IV
- Norwood-Hamilton IIa to V
- Active hair loss within last 12 months
Exclusion
- Photosensitivity to laser light
- Malignancy in the target area
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00947505
Start Date
August 1 2009
End Date
August 1 2010
Last Update
July 30 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Abe Marcadis, M.D.
Palm Beach, Florida, United States, 33409
2
Michael Jarratt, MD
Austin, Texas, United States, 78759